PMID- 11914421 OWN - NLM STAT- MEDLINE DCOM- 20020522 LR - 20190514 IS - 0028-3878 (Print) IS - 0028-3878 (Linking) VI - 58 IP - 6 DP - 2002 Mar 26 TI - HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. PG - 973-5 AB - AD is associated with the A2 allele of the human leukocyte antigen (HLA). However, it is not currently known whether there is any difference between A2 homozygotes and A2 heterozygotes. The authors studied 458 patients with AD and found that A2 homozygotes had earlier onset of AD than either A2 heterozygotes (5.4 years, p = 0.002) or those without A2 (5.2 years, p = 0.003). The "recessive" nature of this association suggests that loss of function at the HLA-A locus or a closely linked gene is associated with AD. FAU - Zareparsi, S AU - Zareparsi S AD - Department of Neurology, Oregon Health Sciences University, Portland 97201, USA. zarepars@ohsu.edu FAU - James, D M AU - James DM FAU - Kaye, J A AU - Kaye JA FAU - Bird, T D AU - Bird TD FAU - Schellenberg, G D AU - Schellenberg GD FAU - Payami, H AU - Payami H LA - eng GR - U24 AG021886/AG/NIA NIH HHS/United States GR - AG-08017/AG/NIA NIH HHS/United States GR - AG05136/AG/NIA NIH HHS/United States GR - P30 AG 10133/AG/NIA NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Neurology JT - Neurology JID - 0401060 RN - 0 (HLA-A2 Antigen) SB - IM MH - Age of Onset MH - Aged MH - Aged, 80 and over MH - Alleles MH - Alzheimer Disease/epidemiology/*genetics MH - Female MH - *Genetic Carrier Screening MH - HLA-A2 Antigen/*genetics MH - *Homozygote MH - Humans MH - Male MH - Middle Aged EDAT- 2002/03/27 10:00 MHDA- 2002/05/25 10:01 CRDT- 2002/03/27 10:00 PHST- 2002/03/27 10:00 [pubmed] PHST- 2002/05/25 10:01 [medline] PHST- 2002/03/27 10:00 [entrez] AID - 10.1212/wnl.58.6.973 [doi] PST - ppublish SO - Neurology. 2002 Mar 26;58(6):973-5. doi: 10.1212/wnl.58.6.973.